Preterm and infection-driven preterm labor: The role of peroxisome proliferator-activated receptors and retinoid X receptor

Reproduction

Volumn 137, Issue 6, 2009, Pages 1007-1015

  Holdsworth Carson, Sarah J ^a,b   Permezel, Michael ^a,b   Rice, Greg E ^c   Lappas, Martha ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MERCY HOSPITAL FOR WOMEN   (Australia)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOID X RECEPTOR; RETINOID X RECEPTOR ALPHA; TUBULIN;

AMNION; AMNION SAC RUPTURE; ARTICLE; CHORIOAMNIONITIS; CONTROLLED STUDY; DECIDUA; DISEASE ASSOCIATION; DNA BINDING; DOWN REGULATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS; FETUS WEIGHT; GENE EXPRESSION; GESTATION PERIOD; GESTATIONAL AGE; HORMONE ACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION; LABOR INDUCTION; MEMBRANE RUPTURE; PLACENTA; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VAGINAL DELIVERY; WESTERN BLOTTING;

ADULT; AMNION; BINDING SITES; BLOTTING, WESTERN; CHORIOAMNIONITIS; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; GESTATIONAL AGE; HUMANS; MALE; OBSTETRIC LABOR, PREMATURE; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PLACENTA; PPAR ALPHA; PPAR DELTA; PPAR GAMMA; PREGNANCY; REAL-TIME POLYMERASE CHAIN REACTION; RETINOID X RECEPTOR ALPHA; RNA, MESSENGER;

EID: 68949206603     PISSN: 14701626     EISSN: 17417899     Source Type: Journal    
DOI: 10.1530/REP-08-0496     Document Type: Article

References (57)

1. Ackerman W, Zhang X, Rovin B & Kniss D 2005 Modulation of cytokine-induced cyclooxygenase 2 expression by PPARγ ligands through NFkB signal disruption in human WISH and amnion cells. Biology of Reproduction 73 527-535.
2. Barak Y, Nelson M, Ogn E, Jones Y, Ruiz-Lozano P, Chien K, Koder A & Evan R 1999 PPARγ is required for placental, cardiac, and adipose tissue development. Molecular Cell 4 585-595.
3. Bensinger S & Tontonoz P 2008 Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature 454 470-477.
4. Berry E, Eykholt R, Helliwell R, Gilmour R, Mitchell M & Marvin K 2003 Peroxisome proliferator-activated receptor isoform expression changes in human gestational tissues with labor at term. Molecular Pharmacology 64 1586-1590.
5. Borel V, Gallot D, Marceau G, Sapin V & Blanchon L 2008 Placental implications of peroxisome proliferator-activated receptors in gestation and parturition. PPAR Research 2008 758562.
6. Capparuccia L, Marzioni D, Giordano A, Fazioli F, De Nictolis M, Busso N, Todros T & Castellucci M 2002 PPARγ expression in normal placenta, hydatidiform mole and choriocarcinoma. Molecular Human Reproduction 8 574-579.
7. Daynes R & Jones D 2002 Emerging roles of PPARs in inflammation and immunity. Nature Reviews Immunology 2 748-759.
8. Delerive P, Fruchart J-C & Staels B 2001 Peroxisome proliferator-activated receptors in inflammation control. Journal of Endocrinology 169 453-459.
9. Dreyer C, Krey G, Keller H, Givel F, Helftenbein G & Wahli W 1992 Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell 68 879-887.
10. Dunn-Albanese LR, Ackerman WE, Xie Y, Iams JD & Kniss D 2004 A reciprocol expression of peroxisome proliferator-activated receptor-gamma and cyclooxygenase-2 in human term parturition. American Journal of Obstetrics and Gynecology 190 809-816.
11. Fahey J 2008 Clinical management of intra-amniotic infection and chorioamnionitis: A review of the literature. Journal of Midwifery & Women's Health 53 227-235.
12. Feingold K, Wang Y, Moser A, Shigenaga J & Grunfeld C 2008 LPS decreases fatty acid oxidation and nuclear hormone receptors in the kidney. Journal of Lipid Research 49 2179-2187.
13. Fortunato S & Menon R 2001 Distinct molecular events suggest different pathways for preterm labor and premature rupture of membranes. American Journal of Obstetrics and Gynecology 184 1399-1406.
14. Fournier T, Tsatsaris V, Handschuh K & Evain-Brion D 2007 PPARs and the placenta. Placenta 28 65-76.
15. French J & McGregor J 1996 The pathobiology of premature rupture of membranes. Seminars in Perinatology 20 344-368.
16. Froment P, Gizard F, Defever D, Staels B, Dupont J & Monget P 2006 Peroxisome proliferator-activated receptors in reproductive tissues: from gametogenesis to parturition. Journal of Endocrinology 189 199-209.
17. Gargano JW, Holzman C, Senagore P, Thorsen P, Skogstrand K, Hougaard DM, Rahbar MH & Chung H 2008 Mid-pregnancy circulating cytokine levels, histologic chorioamnionitis and spontaneous preterm birth. Journal of Reproductive Immunology 79 100-110.
18. Giannoulias D, Haluska G, Gravett M, Sadowsky D, Challis J & Novy M 2005 Localization of prostaglandin H synthase, prostaglandin dehydrogenase, corticotropin releasing hormone and glucocorticoid receptor in rhesus monkey fetal membranes with labor and in the presence of infection. Placenta 26 289-297.
19. Goldenberg R, Andrews W & Hauth H 2002 Choriodecidual infection and preterm birth. Nutrition Reviews 60 S19-S25.
20. Goldenberg R, Culhane IF, Iams JD & Romero R 2008 Epidemiology and causes of preterm birth. Lancet 371 75-84.
21. Hill M, Young M, McCurdy C & Gimble J 1997 Decreased expression of murine PPARγ in adipose tissue during endotoxemia. Endocrinology 138 3073-3076.
22. Holdsworth-Carson S, Permezel M, Riley C, Rice G & Lappas M 2009 Peroxisome proliferator-activated receptors and retinoid X receptor-alpha in term human gestational tissues: Tissue specific and labour-associated changes. Placenta 30 176-186.
23. Issernann I & Green S 1990 Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347 645-650.
24. Jiang C, Ting A & Seed B 1998 PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature 391 82-86.
25. Keelan J, Helliwell R, Nijmeijer B, Berry E, Sato T, Marvin K, Mitchell M & Gilmour R 2001 15-Deoxy-deltal2, 14-prostaglandin J2-induced apoptosis in amnion-like WISH cells. Prostaglandins & Other Lipid Mediators 66 265-282.
26. Kielian T. Syed M, Liu S, Phulwani N, Phillips N, Wagoner G, Drew P & Esen N 2008 The synthetic peroxisome proliferator-activated receptor-γ agonist ciglitazone attenuates neuroinflarnmation and accelerates encapsulation in bacterial brain abscesses. Journal of Immunology 180 5004-5016.
27. Kim YH, Choi SY, Sub JH, Kim TK, Seung KB, Wang YP & Chang K 2008 The effect of Chlamydia pneumoniae on the expression of peroxisome proliferator-activated receptor-gamma in vascular smooth muscle cells. Yonsei Medical Journal 49 230-236.
28. Lamont R 2001 Infection in preterm labour. In Infection and Pregnancy, pp 305-317. Eds A MacLean, L Regan & D Carrington. London: RCOG Press.
29. Lappas M, Permezel M, Geogiou H & Rice G 2002a Nuclear factor kappa B regulation of proinflammatory cytokines in human gestational tissues in vitro. Biology of Reproduction 67 668-673.
30. Lappas M, Permezel M, Georgiou H & Rice G 2002b Regulation of proinflammatory cytokines in human gestational tissues by peroxisome proliferator-activated receptor-γ: Effect of 15-deoxy-D(12,14)-PGJ2 and troglitazone. Journal of Clinical Endocrinology and Metabolism 87 4667-4672.
31. Lappas M, Permezel M, Ho P, Moseley J, Włodek ME & Rice G 2004 Effects of nuclear factor-kappa B inhibitors and peroxisome proliferator-activated receptor-gamma ligands on PTHrP release from human fetal membranes. Placenta 25 699-704.
32. Lappas M, Permezel M & Rice G 2007 Mitogen-activated protein kinase proteins regulate LPS-stimulated release of pro-inflammatory cytokines and prostaglandins from human gestational tissues. Placenta 28 936-945.
33. Laws P, Abeywardana S, Walker J & Sullican E 2007 Australia's mothers and babies 2005. in Perinatal Statistics Series No 20. Sydney: AIHW National Perinatal Statistics Unit.
34. Lim H & Dey S 2000 PPARδ functions as a prostacyclin receptor in blastocyst implantation. Trends in Endocrinology and Metabolism 11 137-142.
35. Lindstrom T & Bennett P 2005 15-Deoxy-D12, 14-prostaglandin J2 inhibits interleukin-lb-induced nuclear factor-κB An human amnion and myometrial cells: Mechanisms and implications. Journal of Clinical Endocrinology and Metabolism 90 3534-3543:
36. Livak K & Schmittgen T 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2-QDCT method. Methods 25 402-408.
37. Mangelsdorf D & Evans RM 1995 The RXR heterodimers and orphan receptors. Cell 83 841-850.
38. McParland P & Bell S 2004 The fetal membranes and mechanisms underlying their labour-associated and pre-labour rupture during pregnancy. Fetal and Maternal Medicine Review 15 73-108.
39. Van Meir C, Sangha R, Walton J, Matthews E, Keirse M & Challis J 1996 Immunoreactive 115-hydroxyprostaglandin dehydrogenase (PGDH) is reduced in fetal membranes from patients at preterm delivery in the presence of infection. Placenta 17 291-297.
40. Van Meir C, Matthews S, Keirse M, Ramirez M, Bocking A & Challis 1997 5-Hydroxyprostaglandin dehydrogenase: Implications in preterm labor with and without ascending infection. Journal of Clinical Endocrinology and Metabolism 82 969-976.
41. Meirhaeghe A, Borehain CA, Murray LJ, Richard F, Davey Smith G, Young IS & Amouyel P 2007 A possible role for the PPARG-Pro12Ala polymorphism in preterm birth. Diabetes 56 494-498.
42. Menon R & Fortunato SJ 2004 The role of matrix degrading enzymes and apoptosis in rupture of membranes. Journal of the Society for Gynecologic Investigation 11 427-437.
43. Perez A, van Heeckeren A, Nichols D, Gupta S, Eastman J & Davis P 2008 Peroxisome proliferator-activated receptor-γ in cystic fibrosis lung epithelium. American Journal of Physiology Lung Cellular and Molecular Physiology 295 L303-L313.
44. Premyslova M, Li W, Alfaidy N, Bocking A, Campbell K, Gibb W & Challis J 2003 Differential expression and regulation of microsomal prostaglandin E2 synthasein human fetal membranes and placenta with infection and in cultured trophoblast cells. Journal of Clinical Endocrinology and Metabolism 88 6040-6047.
45. Redline R 2006 Inflammatory responses in the placenta and umbilical cord. Seminars in Fetal & Neonatal Medicine 11 296-301.
46. Redline R, Faye-Petersen O, Heller D, Qureshi F, Savell V & Vogler C 2003 Amniotic infection syndrome; nosology and reproducibility of placental - reaction patterns. Pediatric and Developmental Pathology 6 435-448.
47. Reti NG, Lappas M, Riley C, Wlodek M, Permezel M, Walker S & Rice G 2007 Why do membranes rupture at term? Evidence of increased cellular apoptosis in the supracervical fetal membranes. American Journal of Obstetrics and Gynecology 196 484e.1-484e.10.
48. Ricote M, Li A, Willson T, Kelly C & Glass C 1998 The peroxisome proliferator-activated receptor-gamma is a negative regulator of machrophage activation. Nature 391 79-82.
49. Rodie V, Young A, Jordan F, Sattar N, Greer J & Freeman D 2005 Human placental peroxisome proliferator-activated receptor δ and γ expression in healthy pregnancy and in preeclampsia and intrauterine growth restriction. Journal of the Society for Gynecologic Investigation 12 320-329.
50. Romero R, Espinoza J, Goncalves L, Kusanovic J, Friel L & Nein J 2006 Inflammation in preterm and term labour and delivery. Seminars in Fetal & Neonatal Medicine 11 317-326.
51. Saigal S & Doyle L 2008 An overview of mortality ind sequelae of preterm birth from infancy to adulthood. Lancet 371 261-269.
52. Schaiff WT, Barak Y & Sadovsky Y 2006 The pleiotropic function of PPARg in the placenta. Molecular and Cellular Endocrinology 249 10-15.
53. Tarrade A, Schoonjans K, Pavan L, Auwerx J, Rochette-Egly C, Evain-Brion D & Fournier T 2001 PPARγ/RXRα heterodimers control human trophoblast invasion. Journal of Clinical Endocrinology and Metabolism 86 5017-5024.
54. Waite L, Person E, Zhou Y, Lim K, Scanlan T & Taylor R 2000 Placental peroxisome proliferator-activated receptorg is up-regulated by pregnancy serum. Journal of Clinicai Endocrinology and metabolism 85 3808-3814.
55. Wang Q, Fujii H & Knipp GT 2002 Expression of PPAR and RXR isoforms in the developing rat and human term placentas. Placenta 23 661-671.
56. Wieser F, Waite L, Depoix C & Taylor R 2008 PPAR action in human placental development and pregnancy and its complications. PPAR Research 2008 1-14.
57. Yang W-L, & Frucht H 2001 Activation of the PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells. Carcinogenesis 22 1379-1383.